The suppression of the mammalian target of rapamycin (mTOR), the downstream target of Akt signaling, has been found to reduce invasion and cell migration as well as block CSCs from forming in NSCLC [18,19]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.